TranslationalLongevity Summit

Leader in diabetes cure-focused research, cell transplantation, and regenerative medicine, invented the technology for large-scale isolation of pancreatic islets, now used worldwide, and performed the first successful islet allotransplants. His interests include also Healthspan and Regenerative Biotherapeutics for prevention and treatment of acute and age-related diseases, to extend healthy lifespan. Author of >1,250 publications (H-index 123), including The Healthspan Code and Therapeutic Revolution.

HRH Princess Dr. Al Saud’s career spans leadership roles at the King Abdulaziz City for Science & Technology (KACST), including Director of the Saudi National Center for Genomics Technology and Director of the Saudi National Pre-Marital Screening Program, alongside population genetics research at King Faisal Specialist Hospital and Research Center. She serves on national and international committees including the Saudi Genome Project 2.0, the G20 S20 Future of Health Taskforce, and the National Biotech Strategy Advisory Committee. She holds a PhD in Genomics of Common Diseases from Imperial College London.

Dr. David Barzilai is a longevity medicine physician, health services researcher, and Harvard Medical School lecturer dedicated to extending human healthspan. He bridges the gap between frontier geroscience and practical clinical application, specializing in evidence-based lifestyle medicine and precision diagnostics. Dr. Barzilai serves as an inaugural faculty member and trustee at the Geneva College of Longevity Science and was the medical editor for Harvard Health Publishing's first special report on longevity. Known widely in the medical community and on social media as "@agingdoc1," he is a leading voice in translating complex aging research into actionable, personalized health strategies.